Skip to main content

Advertisement

SpringerLink
Log in

Nutrition in inflammatory bowel disease

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

The nutritional impact of inflammatory bowel disease is notable, both in Crohn’s disease and ulcerative colitis. The causes of malnutrition include decreased intake, maldigestion, malabsorption, accelerated nutrient losses, increased requirements, and drug-nutrient interactions. Inflammatory bowel disease causes alterations in body composition and, because of these changes, affects energy expenditure. Various approaches have been most effective in correcting malnutrition, supporting growth, and managing short-bowel syndrome, but the success of primary therapy has been limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Griffiths A: Inflammatory bowel disease. In Modern Nutrition in Health and Disease, edn 9. Edited by Shils M, Olson J, Shike M, et al. Baltimore: Williams & Wilkins; 1999:1141–1161. This is an up-to-date review of nutrition and IBD highlighting the role of diet in pathogenesis of IBD, effects of these diseases on nutritional status, and nutritional support in IBD.

    Google Scholar 

  2. Gokhale R, Favus M, Karrison T, et al.: Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998, 114:902–911.

    Article  PubMed  CAS  Google Scholar 

  3. Robinson R, Krzywicki T, Almond L, et al.: Effect of a low-impact exercise program on bone mineral density in Crohn’s disease: a randomized controlled trial. Gastroenterology 1998, 115:36–41.

    Article  PubMed  CAS  Google Scholar 

  4. Mingrone G, Greco A, Benedetti G, et al.: Increased resting lipid oxidation in Crohn’s disease. Dig Dis Sci 1996, 41:72–76.

    Article  PubMed  CAS  Google Scholar 

  5. Royall D, Greenberg G, Allard J, et al.: Total enteral nutrition support improves body composition of patients with active Crohn’s disease. J Parenter Enteral Nutr 1995, 19:95–99.

    CAS  Google Scholar 

  6. Mingrone G, Benedetti G, Capristo E, et al.: Twenty-four hour energy balance in Crohn disease patients: metabolic implications of steroid treatment. Am J Clin Nutr 1998, 67:118–123.

    PubMed  CAS  Google Scholar 

  7. Tjellesen L, Nielsen P, Staun M: Body composition by dual-energy X-ray absorptiometry in patients with Crohn’s disease. Scand J Gastroenterol 1998,33:956–960.

    Article  PubMed  CAS  Google Scholar 

  8. Azcue M, Rashid M, Griffiths A, et al.: Energy expenditure and body composition in children with Crohn’s disease: effect of enteral nutrition and treatment with prednisolone. Gut 1997, 47:2203–2208. This study provides data to support failure to adapt the resting energy expenditure to the decrease in lean body weight observed in pediatric patients with CD. This explains the weight loss and malnutrition that occurs in this group of patients.

    Google Scholar 

  9. Zoli G, Katelaris P, Garrow J, et al.: Increased energy expenditure in growing adolescents with Crohn’s disease. Dig Dis Sci 1996, 41:1754–1759.

    Article  PubMed  CAS  Google Scholar 

  10. Geerling B, Badart-Smook A, Stockbrugger R, et al.: Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 1998, 67:919–926. This article compares various measures of nutritional assessment in patients with long-standing but quiescent CD to findings in healthy control subjects. Based on these data, a composite of assessment techniques is proposed which accurately evaluates nutritional status in patients with CD.

    PubMed  CAS  Google Scholar 

  11. Trallori M, D‘Albasio G, Milla M, et al.: Defined-formula diets versus steroids in the treatment of active Crohn’s disease. Scand J Gastroenterol 1996, 31:267–272.

    PubMed  Google Scholar 

  12. Fernandez-Barares F, Cabre E, Esteve-Comas M, et al.: How effective is enteral nutrition in inducing clinical remission in active Crohn’s disease? A meta-analysis of the randomized controlled trials. J Parenter Enteral Nutr 1995, 19:356–362.

    Google Scholar 

  13. Griffiths A, Ohlsson A, Sherman P, et al.: Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology 1995, 108:1056–1067.

    Article  PubMed  CAS  Google Scholar 

  14. Ferguson A, Glen M, Ghosh S: Crohn’s disease: nutrition and nutritional therapy. Baillieres Clin Gastroenterol 1998, 12:93–114. This is a comprehensive review of nutrition and CD that critically assesses various modalities of nutritional therapy.

    Article  PubMed  CAS  Google Scholar 

  15. Wilschanski M, Sherman P, Pencharz P, et al.: Supplementary enteral nutrition maintains remission in paediatric Crohn’s disease. Gut 1996, 38:543–548.

    PubMed  CAS  Google Scholar 

  16. Lorenz-Meyer H, Bauer P, Nicolay C, et al.: Omega-3 fatty acids and low carbohydrate for maintenance of remission in Crohn’s disease. Scand J Gastroenterol 1996, 31:778–785.

    PubMed  CAS  Google Scholar 

  17. Khoshoo F, Reifen R, Neuman M, et al.: Effect of low-and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn’s disease. J Parenter Enteral Nutr 1996, 20:401–405.

    Article  CAS  Google Scholar 

  18. Scolapio J, Fleming C, Kelly D, et al.: Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc 1999, 74:217–222.

    Article  PubMed  CAS  Google Scholar 

  19. Sturniolo G, Mestriner C, Lecis P, et al.: Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol 1998, 33:644–649.

    Article  PubMed  CAS  Google Scholar 

  20. Lashner B, Provencher K, Seidner D, et al.: The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997, 12:29–32.

    Article  Google Scholar 

  21. Beattie M, Bentsen B, MacDonald T: Childhood Crohn’s disease and the efficacy of enteral diets. Nutrition 1998, 14:345–350. This review not only discusses available data that establish a role for enteral nutritional support in pediatric patients with CD but also discusses possible mechanisms by which enteral nutrition plays a role in therapy.

    Article  PubMed  CAS  Google Scholar 

  22. Breese E, Michie C, Nicholls S, et al. Tumor necrosis factor-a producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994, 106:1455–1466.

    PubMed  CAS  Google Scholar 

  23. Breese E, Michie C, Nicholls S, et al.: The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn’s disease. Aliment Pharmacol Ther 1995, 9:547–552.

    Article  PubMed  CAS  Google Scholar 

  24. Kelly D, Fleming C: Nutritional considerations in inflammatory bowel diseases. Gastroenterol Clin NA 1995, 24:597–611.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Medical School, Mayo Clinic, 55905, Rochester, MN, USA

    Darlene G. Kelly MD

Authors
  1. Darlene G. Kelly MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelly, D.G. Nutrition in inflammatory bowel disease. Curr Gastroenterol Rep 1, 324–330 (1999). https://doi.org/10.1007/s11894-999-0117-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-999-0117-0

Keywords

Search

Navigation